References
- Sampson JH, Heimberger AB, Archer GE, Aldape KD, Friedman AH, Friedman HS, Gilbert MR, Herndon JE, McLendon RE, Mitchell DA et al. Immunologic escape after prolonged progression-free survival with epidermal growth factor receptor variant III peptide vaccination in patients with newly diagnosed glioblastoma. J Clin Oncol 2010; 28:4722-9; PMID:20921459; http://dx.doi.org/10.1200/JCO.2010.28.6963
- Lohr J, Ratliff T, Huppertz A, Ge Y, Dictus C, Ahmadi R, Grau S, Hiraoka N, Eckstein V, Ecker RC et al. Effector T-cell infiltration positively impacts survival of glioblastoma patients and is impaired by Tumor-derived TGF. Clin Cancer Res 2011; 17:4296-308; PMID:21478334; http://dx.doi.org/10.1158/1078-0432.CCR-10-2557
- Beckhove P, Warta R, Lemke B, Stoycheva D, Momburg F, Schnölzer M, Warnken U, Schmitz-Winnenthal H, Ahmadi R, Dyckhoff G et al. Rapid T cell–based identification of human tumor tissue antigens by automated two-dimensional protein fractionation. J Clin Invest 2010; 120:2230-42; PMID:20458140; http://dx.doi.org/10.1172/JCI37646
- Dutoit V, Herold-Mende C, Hilf N, Schoor O, Beckhove P, Bucher J, Dorsch K, Flohr S, Fritsche J, Lewandrowski P et al. Exploiting the glioblastoma peptidome to discover novel tumour-associated antigens for immunotherapy. Brain 2012; 135:1042-54; PMID:22418738; http://dx.doi.org/10.1093/brain/aws042
- Coronell JAL, Syed P, Sergelen K, Gyurján I, Weinhäusel A. The current status of cancer biomarker research using tumour-associated antigens for minimal invasive and early cancer diagnostics. J Proteomics 2012; 76:102-15; PMID:22842156; http://dx.doi.org/10.1016/j.jprot.2012.07.022
- Mock A, Warta R, Geisenberger C, Bischoff R, Schulte A, Lamszus K, Stadler V, Felgenhauer T, Schichor C, Schwartz C et al. Printed peptide arrays identify prognostic TNC serumantibodies in glioblastoma patients. Oncotarget 2015; 6:13579-90; PMID:25944688; http://dx.doi.org/10.18632/oncotarget.3791
- Stadler V, Felgenhauer T, Beyer M, Fernandez S, Leibe K, Güttler S, Gröning M, König K, Torralba G, Hausmann M et al. Combinatorial synthesis of peptide arrays with a laser printer. Angew Chem Int Ed 2008; 47:7132-5; PMID:18671222; http://dx.doi.org/10.1002/anie.200801616
- Geisenberger C, Mock A, Warta R, Rapp C, Schwager C, Korshunov A, Nied A-K, Capper D, Brors B, Jungk C et al. Molecular profiling of long-term survivors identifies a subgroup of glioblastoma characterized by chromosome 19/20 co-gain. Acta Neuropathol 2015; 130(3):419-34; PMID:25931051; http://dx.doi.org/10.1007/s00401-015-1427-y
- Brennan CW, Verhaak RGW, McKenna A, Campos B, Noushmehr H, Salama SR, Zheng S, Chakravarty D, Sanborn JZ, Berman SH et al. The somatic genomic landscape of glioblastoma. Cell 2013; 155:462-77; PMID:24120142; http://dx.doi.org/10.1016/j.cell.2013.09.034